Ncyte® aCardiomyocytes are produced through a well-defined in vitro differentiation process from human induced pluripotent stem cells (iPSC) and express typical atrial cell markers, such as COUP-TFII.
These cells are the ideal tool to test your drug’s effect on atrial function. They can be applied throughout the entire drug discovery pipeline, from extensive screening for identifying hits to crucial decision-making stages in hit-to-lead and lead optimization processes.